Pasithea Therapeutics Corp. - Common Stock — Liquidità (NASDAQ:KTTA) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -3.17 M-14.56 M-13.43 M-13.92 M-15.21 M -16.94 M Flussi di cassa derivanti dalle attività di investimento -21.5 K-2.06 M399.01 K011 K — Liquidità derivante dalle attività di finanziamento 55.93 M-3.21 M-3.73 M4.52 M63.52 M 62.05 M Liquidità libera -3.17 M-14.56 M-14.43 M-13.92 M-15.21 M -16.94 M

Notizie

Pasithea nomina Kartik Krishnan come chief medical officer

Pasithea riceve lo status Fast Track dalla FDA per farmaco candidato NF1

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

Pasithea fornisce aggiornamenti sui trial clinici per il farmaco inibitore MEK

Pasithea provides updates on clinical trials for MEK inhibitor drug

Pasithea Therapeutics torna conforme alle regole del Nasdaq sul prezzo minimo

Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule

Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Crude Oil Gains 1%; Tilray Brands Shares Plunge - Rich Sparkle Holdings (NASDAQ:ANPA), HeartBeam (NASDAQ:BEAT)

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.67%